General Information of the Compound
| Compound ID |
CP0066106
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
(-)-alpha-Amino-p-hydroxyhydrocinnamic acid
(S)-2-Amino-3-(4-hydroxyphenyl)propionic acid
(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid
(S)-3-(p-Hydroxyphenyl)alanine
(S)-Tyrosine
(S)-alpha-Amino-4-hydroxybenzenepropanoic acid
2-Amino-3-(p-hydroxyphenyl)propionic acid
3-(4-Hydroxyphenyl)-L-alanine
3-(p-Hydroxyphenyl)alanine
4-Hydroxy-L-phenylalanine
4ts1
Alpha-Amino-beta-(4-hydroxyphenyl)propionic acid
Beta-(p-Hydroxyphenyl)alanine
DD69927C-C6A8-4BC6-8E9A-0AB423B176E7
DTY
Free-Form L-Tyrosine
H-Tyr-OH
L-(-)-Tyrosine
L-2-Amino-3-p-hydroxyphenylpropanoic acid
L-Tyrosin
L-Tyrosine
L-Tyrosine (9CI)
L-Tyrosine (JAN)
L-Tyrosine hydrochloride
L-Tyrosine, homopolymer
L-Tyrosine, monomer
L-p-Tyrosine
Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs
Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide
Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide, <3 kd fraction
Melanin synthesized from Tyr substrate catalyzed by tyrosinase, brominated with N-bromosuccinimide
Melanin synthesized from Tyr substrate catalyzed by tyrosinase, sulfonated using sulfur trioxide/DMF complex for 1.5-7 hours
P-Tyrosine
Rxosine
TYR NH3+ COOH
Tirosina
Tirosina [Spanish]
Tyr
Tyrosine
Tyrosine (USP/INN)
Tyrosine (VAN)
Tyrosine Power
Tyrosine [USAN:INN]
Tyrosine, L-(8CI)
Tyrosinum
Tyrosinum [Latin]
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H11NO3
|
||||||||||||||||||
| Molecular Weight |
181.191
|
||||||||||||||||||
| Canonical SMILES |
N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
OUYCCCASQSFEME-QMMMGPOBSA-N
|
||||||||||||||||||
| CAS |
140-43-2
1991-85-1
46209-14-7
55520-40-6
25619-78-7
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound